Mathematical models for dengue fever epidemiology: A 10-year systematic review

M Aguiar, V Anam, KB Blyuss, CDS Estadilla… - Physics of Life …, 2022 - Elsevier
Mathematical models have a long history in epidemiological research, and as the COVID-19
pandemic progressed, research on mathematical modeling became imperative and very …

A recombinant, chimeric tetravalent dengue vaccine candidate based on a dengue virus serotype 2 backbone

JE Osorio, D Wallace, DT Stinchcomb - Expert Review of Vaccines, 2016 - Taylor & Francis
Dengue fever is caused by infection with one of four dengue virus (DENV) serotypes (DENV-
1–4), necessitating tetravalent dengue vaccines that can induce protection against all four …

Three-month real-time dengue forecast models: an early warning system for outbreak alerts and policy decision support in Singapore

Y Shi, X Liu, SY Kok, J Rajarethinam… - Environmental …, 2016 - ehp.niehs.nih.gov
Background: With its tropical rainforest climate, rapid urbanization, and changing
demography and ecology, Singapore experiences endemic dengue; the last large outbreak …

Assessing the suitability for Aedes albopictus and dengue transmission risk in China with a delay differential equation model

S Metelmann, X Liu, L Lu, C Caminade… - PLOS neglected …, 2021 - journals.plos.org
Dengue is considered non-endemic to mainland China. However, travellers frequently
import the virus from overseas and local mosquito species can then spread the disease in …

Why should we apply ABM for decision analysis for infectious diseases?—An example for dengue interventions

F Miksch, B Jahn, KJ Espinosa, J Chhatwal, U Siebert… - PloS one, 2019 - journals.plos.org
For the evaluation of infectious-diseases interventions, the transmissible nature of such
diseases plays a central role. Agent-based models (ABM) allow for dynamic transmission …

[HTML][HTML] Estimation of parameters related to vaccine efficacy and dengue transmission from two large phase III studies

L Coudeville, N Baurin, E Vergu - Vaccine, 2016 - Elsevier
Background A tetravalent dengue vaccine was shown to be efficacious against symptomatic
dengue in two phase III efficacy studies performed in five Asian and five Latin American …

[HTML][HTML] Potential impact of dengue vaccination: Insights from two large-scale phase III trials with a tetravalent dengue vaccine

L Coudeville, N Baurin, M L'Azou, B Guy - Vaccine, 2016 - Elsevier
Background A tetravalent dengue vaccine demonstrated its protective efficacy in two phase
III efficacy studies. Results from these studies were used to derive vaccination impact in the …

Feasibility and willingness to pay for dengue vaccine in the threat of dengue fever outbreaks in Vietnam

LH Nguyen, BX Tran, CD Do, CL Hoang… - Patient preference …, 2018 - Taylor & Francis
Background The escalation of dengue fever (DF) cases in recent years and the occurrence
of a large-scale DF outbreak in 2017 underline the importance of dengue vaccines in …

Dengueme: A tool for the modeling and simulation of dengue spatiotemporal dynamics

TFM De Lima, RM Lana, TG de Senna Carneiro… - International journal of …, 2016 - mdpi.com
The prevention and control of dengue are great public health challenges for many countries,
particularly since 2015, as other arboviruses have been observed to interact significantly …

[PDF][PDF] Biological view of vaccination described by mathematical modellings: From rubella to dengue vaccines

HM Yang, ARR Freitas - Math. Biosci. Eng, 2019 - researchgate.net
The only rubella vaccine available in North America is the RA27/3 strain (isolated from the
kidney of a rubella-infected fetus and attenuated) licensed in 1979, which substituted …